New drug combo shows promise for hard-to-treat myeloma
NCT ID NCT03731832
First seen Sep 30, 2025 · Last updated May 15, 2026 · Updated 31 times
Summary
This study tested a combination of three drugs (pomalidomide, ixazomib, and dexamethasone) with or without a fourth drug (cyclophosphamide) in 66 adults with multiple myeloma that had come back or stopped responding to treatment. The goal was to see how well the drugs could control the cancer. Participants took the drugs by mouth, and the study measured how many people's tumors shrank or stabilized. This is not a cure, but aims to manage the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kliniken Ostalb Stauferklinikum Schwäbisch Gmünd
Mutlangen, 73557, Germany
-
Klinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main
Frankfurt am Main, 60590, Germany
-
Klinikum rechts der Isar der TU München / III. Med. Klinik und Poliklinik
Munich, Bavaria, 81675, Germany
-
Sozialstiftung Bamberg / Klinik am Bruderwald, Zentrum für Innere Medizin, Med. Klinik V, Hämatologie und internistische Onkologie
Bamberg, 96049, Germany
-
Studienzentrum Onkologie Ravensburg
Ravensburg, 88212, Germany
-
Universitätsklinikum Jena / Klinik für Innere Medizin II, Abteilung für Hämatologie und internistische Onkologie
Jena, 07747, Germany
-
Universitätsklinikum Magdeburg A.Ö.R / Klinik für Hämatologie und Onkologie
Magdeburg, 39120, Germany
-
Universitätsklinikum Münster / Medizinische Klinik A
Münster, 48149, Germany
-
Universitätsklinikum Ulm / Klinik für Innere Medizin III
Ulm, 89081, Germany
-
Universitätsklinikum Würzburg
Würzburg, 97080, Germany
-
phase drei Hämato-Onkologischer Studienkreis am Klinikum Aschaffenburg
Aschaffenburg, 63739, Germany
Conditions
Explore the condition pages connected to this study.